financetom
Business
financetom
/
Business
/
T-Mobile, Starlink to launch satellite-based connectivity in July for $15 per month
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
T-Mobile, Starlink to launch satellite-based connectivity in July for $15 per month
Feb 10, 2025 2:40 AM

Feb 9 (Reuters) - T-Mobile said on Sunday it

will launch its satellite-to-cell service, powered by SpaceX's

Starlink, in July for $15 a month, as the U.S. wireless carrier

aims to eliminate mobile dead zones and extend connectivity to

remote areas.

Shares of T-Mobile rose about 4% in premarket trading on

Monday.

The move could mark a pivotal shift in mobile connectivity,

bridging the gap between traditional cell networks and satellite

technology to ensure seamless coverage anywhere on Earth.

T-Mobile said 500,000 square miles of the U.S., which is

unreachable by terrestrial cell towers, can now stay connected.

The carrier began a wide-scale beta trial of the service on

Sunday. The company will provide the service free for customers

till its launch, after which it will be included in the

carrier's premium Go5G Next plan at no extra cost.

For other plans, customers who sign up for the trial will

get a 33% discount when the service is commercially launched,

the wireless carrier said.

The carrier is also offering the T-Mobile Starlink service

directly to all wireless users, including customers of rival

telecom firms AT&T ( T ) and Verizon without having to

switch.

The beta launch will offer text service via satellite, while

voice and data features will be added later, the company

announced during the Super Bowl game on Sunday.

"This is something that nobody else in the U.S. has done,

and one of the big distinctive things this network has is that

it works across almost all smartphones from the last four

years," Mike Katz, president of marketing, strategy and

products, told Reuters.

T-Mobile has been working closely with Apple ( AAPL ) and

Alphabet's Google to "ensure that this experience is

integrated directly into their OS (operating system), and this

will be the default satellite system across both of those

phones," Katz said.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Advanced Micro Devices Insider Sold Shares Worth $11,509,369, According to a Recent SEC Filing
Advanced Micro Devices Insider Sold Shares Worth $11,509,369, According to a Recent SEC Filing
Nov 9, 2024
04:34 PM EST, 11/08/2024 (MT Newswires) -- Lisa T Su, Director, Chair, President & CEO, on November 06, 2024, sold 80,000 shares in Advanced Micro Devices ( AMD ) for $11,509,369. Following the Form 4 filing with the SEC, Su has control over a total of 4,184,892 shares of the company, with 3,566,762 shares held directly and 618,130 controlled indirectly....
Carrier Global Insider Sold Shares Worth $12,281,698, According to a Recent SEC Filing
Carrier Global Insider Sold Shares Worth $12,281,698, According to a Recent SEC Filing
Nov 9, 2024
04:58 PM EST, 11/08/2024 (MT Newswires) -- Kevin J. O'Connor, Senior Vice President & Chief Legal Officer, on November 06, 2024, sold 167,183 shares in Carrier Global ( CARR ) for $12,281,698. Following the Form 4 filing with the SEC, O'Connor has control over a total of 46,083 shares of the company, with 46,083 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1783180/000122520824009822/xslF345X05/doc4.xml...
Autolus Therapeutics' Leukemia Treatment Receives US FDA Approval
Autolus Therapeutics' Leukemia Treatment Receives US FDA Approval
Nov 9, 2024
04:58 PM EST, 11/08/2024 (MT Newswires) -- Autolus Therapeutics ( AUTL ) said late Friday its Aucatzyl programmed T cell therapy has received marketing authorization from the US Food and Drug Administration for the treatment of adult patients with relapsed or refractory B-cell precursor acute lymphoblastic leukemia. The safety of Aucatzyl includes a boxed warning for cytokine release syndrome, neurologic...
Liberty Global Completes Sunrise Spinoff
Liberty Global Completes Sunrise Spinoff
Nov 9, 2024
04:31 PM EST, 11/08/2024 (MT Newswires) -- Liberty Global ( LBTYA ) said Friday it has completed the spinoff of its Swiss business Sunrise into a separate publicly traded company. The move comes after Liberty shareholders approval on Oct. 25, the company said. Sunrise shares in the form of Sunrise American depository shares will be distributed to Liberty shareholders on...
Copyright 2023-2026 - www.financetom.com All Rights Reserved